Baba Ramdev appeals against criminal action over alleged anti-allopathy remarks during covid pandemic, SC issues notice

Published On 2023-10-11 11:51 GMT   |   Update On 2023-10-11 11:54 GMT
Advertisement

The Supreme Court bench comprising Justices AS Bopanna and MM Sundresh on Monday issued notice on the plea by Patanjali founder Ram Dev seeking protection against coercive action in criminal proceedings initiated against him for his alleged remarks questioning the efficacy of modern medicines like remdesivir and fabiflu and linking them with COVID-19 deaths.

Filing the plea before the Apex Court bench, the Baba Ramdev prayed that the first information reports (FIR) filed against him in various places to be clubbed together and transferred to Delhi or be quashed.

Advertisement

For more details, check out the link given below:

Baba Ramdev Appeals Against Criminal Action Over Alleged Anti-Allopathy Remarks During COVID Pandemic, SC Issues Notice

Full View
Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News